Ivermectin resistance and overview of the Consortium for Anthelmintic Resistance SNPs

Expert Opinion on Drug Discovery

Volumn 2, Issue SUPPL. 1, 2007, Pages

  Prichard, Roger K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anthelmintic resistance; Ivermectin; Lymphatic filariasis; Mechanism of action; Nematode; Onchocerciasis

Indexed keywords

2 DESOXOPARAHERQUAMIDE; 4 AMINOBUTYRIC ACID RECEPTOR; ABC TRANSPORTER; ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE; BETA TUBULIN; CHLOROQUINE; CYCLIC AMP; GLYCOPROTEIN P; IVERMECTIN; LEVAMISOLE; MOXIDECTIN; PARAHERQUAMIDE; PYRANTEL; QUININE; TETRAHYDROPYRIMIDINE; THENIUM; UNCLASSIFIED DRUG; VERAPAMIL;

AFRICA; ANTIBIOTIC RESISTANCE; BLOOD BRAIN BARRIER; DNA HYBRIDIZATION; DNA SPLICING; DRUG HALF LIFE; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; FILARIASIS; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC STABILITY; GENETIC VARIABILITY; HEALTH PROGRAM; HETEROZYGOTE; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; ONCHOCERCIASIS; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRONGYLOIDIASIS; WORKSHOP;

EID: 35448972959     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2.S1.S41     Document Type: Review

References (88)

1. CAMPBELL WC: Ivermectin: an update. Parasitol. Today (1985) 1:10-16.
2. WOODRUFF HB, BURG RW: The antibiotics explosion. In: Discoveries in Pharmacology (Volume 3). Parnham J, Bruinvels J (Eds), Elsevier, The Netherlands (1986):338-341.
3. COTREAU MM, WARREN S, RYAN JL et al.: The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J. Clin. Pharmacol. (2003) 43:1108-1115.
4. AZIZ MA, DIALLO S, LARIVIERE M, DIOP IM, PORTA IM, GAXOTTE P: Ivermectin in onchocerciasis. Lancet (1982) 2:1456-1457.
5. BOATIN BA, HOUGARD JM, ALLEY ES et al.: The impact of Mectizan on the transmission of onchocerciasis. Ann. Trop. Med. Parasitol. (1998) 92(Suppl.):46-6O.
6. DUKE BOL, ZEA-FLORES G, CASTRO J, CUPP EW, MUNOZ B: Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am. J. Trop. Med. Hyg. (1990) 43:657-664.
7. GARDON J, BOUSSINESQ M, KAMGNO J, GARDON-WENDEL N, DEMANGA-NGANGUE, DUKE BOL: Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet (2002) 360:203-210.
8. BLAIR LS, CAMPBELL WC: Efficacy of ivermectin against Dirofilaria immitis larvae in dogs (31, 60 and 90 days after infection). Am. J. Vet. Res. (1980) 41:2108.
9. PRICHARD RK: Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs? Vet. Parasitol. (2005) 133:243-253.
10. TCHAKOUTE VL, BRONSVOORT M, TANYA V, RENZ A, TREES AJ: Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi. Parasitology (1999) 118:195-199.
11. ADDISS DG, BEACH M J, STREIT TG et al.: Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet (1997) 350:480-484.
12. NUESCH R, ZIMMERLI L, STOCKLI R et al.: Imported strongyloidosis: a longitudinal analysis of 31 cases. J. Travel. Med. (2005) 12:80-84.
13. DOURMISHEV AL, DOURMISHEV LA, SCHWARTZ RA: Ivermectin: pharmacology and application in dermatology. Int. J. Dermatol. (2005) 44:981-988.
14. KAPLAN RM: Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. (2004) 20:477-481.
15. LOVERIDGE B, MCARTHUR M, MCKENNA PB, MARIADASS B: Probable multigeneric resistance to macrocyclic lactone anthelmintics in cattle in New Zealand. NZ Vet. J. (2003) 51:139-141.
16. MEJÍA ME, FERNÁNDEZ IGARTÚA BM, SCHMIDT EE, CABARET J: Multispecies and multiple anthelmintic resistance on cattle nematodes in a farm in Argentina: the beginning of high resistance? Vet. Res. (2003) 34:461-467.
17. WOLSTENHOLME AJ, FAIRWEATHER I, PRICHARD R, VON SAMSON-HIMMELSTJERNA G, SANGSTER NC: Drug resistance in veterinary helminths. Trends Parasitol. (2004) 20:469-476.
18. GEARY TM: Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. (2005) 21:530-532.
19. BOERSEMA JH, EYSKER M, NAS JW: Apparent resistance of Parascaris equorum to macrocylic lactones. Vet. Rec. (2002) 150:279-281.
20. HEARN FP, PEREGRINE AS: Identification of foals infected with Parascaris equorum apparently resistant to ivermectin. J. Am. Vet. Med. Assoc. (2003) 223:482-485, 455.
21. TRAWFORD AF, BURDEN F, HODGKINSON J: Suspected moxidectin resistance in cyathostomes in two donkey herds at the Donkey Sanctuary UK. Abstract of the 20th International Conference of the World Association for the Advancement of Veterinary Parasitology, Christchurch, NZ (2005):196.
22. SHOOP WL: Ivermectin resistance. Parasitol. Today (1993) 9:154-159.
23. COLES GC, RHODES AC, WOLSTENHOLME AJ: Rapid selection for ivermectin resistance in Haemonchus contortus. Vet. Parasitol. (2005) 129:345-347.
24. CLARK JM, SCOTT JG, CAMPOS F, BLOOMQUIST JR: Resistance to avermectins: extent, mechanisms, and management implications. Annu. Rev. Entomol. (1995) 40:1-30.
25. HUMERES EC, MORSE JG: Baseline susceptibility of persea mite (Acari: Tetranychidae) to abamectin and milbemectin in avocado groves in Southern California. Exp. App. Acarol. (2005) 36:51-59.
26. CURRIE BJ, HARUMAL P, MCKINNON M, WALTON SF: First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin. Infect. Dis. (2004) 39:E8-E12.
27. ALI MM, MUKHTAR MM, BARAKA OZ, HOMEIDA MM, KHEIR MM, MACKENZIE CD: Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop. (2002) 84:49-53.
28. AWADZI K, BOAKYE DA, EDWARDS G et al.: An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. (2004) 98:231-249.
29. AWADZI K, ATTAH SK, ADDY ET et al.: Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. (2004) 98:359-370.
30. OSEI-ATWENEBOANA MY, ENG JKL, BOAKYE DA, GYAPONG JO, PRICHARD RK: Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a Phase II epidemiological study. Lancet (2007) 369:2021-2029.
31. ENG JK, PRICHARD RK: A comparison of genetic polymorphism in populations of Onchocerca volvolus from untreated- and ivermectin-treated patients. Mol. Biochem. Parasitol. (2005) 142: 193-202.
32. ARDELLI BF, PRICHARD RK: Identification of variant ABC- transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa. Ann. Trop. Med. Parasitol. (2004) 98:371-384.
33. ARDELLI BF, GUERRIERO SB, PRICHARD RK: Genomic organization and effects of ivermectin selection on Onchocerca volvolus P-glycoprotein. Mol. Biochem. Parasitol. (2005) 143:58-66.
34. ARDELLI BF, GUERRIERO SB, PRICHARD RK: Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity. Parasitology (2006) 132:375-386.
35. ARDELLI BF, GUERRIERO SB, PRICHARD RK: Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol. Biochem. Parasitol. (2006) 145:94-100.
36. BOURGUINAT C, PION SDS, KAMGNO J et al.: Genetic selection of low fertile Onchocerca volvolus by ivermectin treatment. PLoS Negl. Trop. Dis. (2007) 1:E72.
37. OTTESEN EA: Lymphatic filariasis: treatment, control and elimination. Adv. Parasitol. (2006) 61:395-441.
38. SCHWAB AE, CHURCHER TS, SCHWAB AJ, BASÁÑEZ M-G, PRICHARD RK: An analysis of the population genetics of potential multi-drug resistance in lymphatic filariasis due to combination chemotherapy. Parasitology (2007) 134:1025-1040.
39. FENG XP, HAYASHI J, BEECH RN, PRICHARD, RK: Study of the nematode putative GABA type A receptor subunits: evidence for modulation by ivermectin. J. Neurochem. (2002) 83:870-878.
40. CULLY DF, VASSILATIS DK, LIU KK et al.: Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature (1994) 371:707-711.
41. DENT JA, SMITH MM, VASSILATIS DK, AVERY L: The genetics of ivermectin resistance in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA (2000) 97:2674-2679.
42. YATES DM, PORTILLO V, WOLSTENHOLME AJ: The avermectin receptors of Haemonchus contortus and Caenorhabditis elegans. Int. J. Parasitol. (2003) 33:1183-1193.
43. NJUE AI, HAYASHI J, KINNE L, FENG X-P, PRICHARD RK: Mutations in the extracellular domains of glutamate-gated chloride channel α3 and β subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity. J. Neurochem. (2004) 89:1137-1147.
44. ARDELLI BF, PRICHARD RK: Synergistic overexpression of ABC transporters defend Caenorhabditis elegans against macrocyclic lactone toxicity. Submitted.
45. SCHULZ-KEY H: Observations on the reproductive biology of Onchocerca volvulus. Acta Leiden (1990) 59:27-44.
46. SHERIFF JC, KOTZE AC, SANGSTER NC, HENNESSY DR: Effect of ivermectin on feeding by Haemonchus contortus in vivo. Vet. Parasitol. (2005) 128:341-346.
47. STROTE G, BONOW I, ATTAH S: The ultrastructure of the anterior end of male Onchocerca volvulus: papillae, amphids, nerve ring and first indication of an excretory system in the adult filarial worm. Parasitology (1996) 113:71-85.
48. BENNETT JL, WILLIAMS JF, DAVE V: Pharmacology of ivermectin. Parasitol. Today (1988) 4:226-228.
49. EDWARDS G, DINGSDALE A, HELSBY N, ORME ML, BRECKENRIDGE AM: The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution. Eur. J. Clin. Pharmacol. (1988) 35:681-684.
50. ETTE EI, THOMAS WO, ACHUMBA JI: Ivermectin: a long-acting microfilaricidal agent. DICP (1990) 24:426-433.
51. BARAKA OZ, MAHMOUD BM, MARSCHKE CK, GEARY TG, HOMEIDA MM, WILLIAMS JF: Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur. J. Clin. Pharmacol. (1996) 50:407-410.
52. POULIOT JF, L'HEUREUX F, LIU Z, PRICHARD RK, GEORGES E: Ivermectin: reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. (1997) 53:17-25.
53. LESPINE A, MARTIN S, DUPUY J et al.: Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. (2007) 30:84-94.
54. MOLENTO MB, LIFSCHITZ A, SALLOVITZ J, LANUSSE C, PRICHARD R: Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep. Parasitol. Res. (2004) 92:121-127.
55. SCHINKEL AH, SMIT JJ, VAN TELLINGEN O et al.: Disruption of the moose mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell (1994) 77:491-502.
56. MEALEY KL, BENTJEN SA, GAY JM, CANTOR GH: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics (2001) 11:727-733.
57. ROULET A, PUEL O, GESTA S et al.: MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur. J. Pharmacol. (2003) 460:85-91.
58. XU M, MOLENTO M, BLACKHALL W, RIBEIRO P, BEECH R, PRICHARD R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. (1998) 91:327-335.
59. BLACKHALL W, LIU HY, XU M, PRICHARD RK, BEECH RN: Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol. Biochem. Parasitol. (1998) 95:193-201.
60. SANGSTER NC, BANNAN SC, WEISS AS, NULF SC, KLEIN RD, GEARY TG: Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins. Exp. Parasitol. (1999) 91:250-257.
61. MOLENTO MB, PRICHARD RK: The effects of the mu]tidrug-resistance-reversing agent verapamil and CL347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitol. Res. (1999) 85:1007-1011.
62. KWA MS, OKOLI MN, SCHULZ-KEY H, OKONGKWO PO, ROOS MH: Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus. Int. J. Parasitol. (1998) 28:1235-1240.
63. HUANG Y-J, PRICHARD RK: Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Mol. Biochem. Parasitol. (1999) 102:273-281.
64. WALL JD, ANDOLFATTO P, PREZEWORSKI M: Testing models of selection and demography in Drosophila simulans. Genetics (2002) 162:203-216.
65. MU J, FERDIG MT, FENG X et al.: Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. (2003) 49:977-989.
66. PRZEWORSKI M: The signature of positive selection at randomly chosen loci. Genetics (2002) 160:1179-1189.
67. NJUE AI, PRICHARD RK: Genetic variability of glutamate gated chloride channel genes in ivermectin-susceptible and -resistant strains of Cooperia oncophora. Parasitology (2004) 129:741-751.
68. SHOOP WL, MROZIK H, FISHER MH: Structure and activity of avermectins and milbemycins in animal health. Vet. Parasitol. (1995) 59:139-156.
69. McCAVERA S, ROGERS AT, WOODS D, WOLSTENHOLME A: Molecular pharmacology of a Haemonchus contortus ivermectin-sensitive channel. Abstract of the ICOPA Congress. Glasgow, UK (2006):A1118.
70. LAUGHTON DL, AMAR M, THOMAS P et al.: Cloning of a putative inhibitory amino acid receptor subunit from the nematode Haemonchus contortus. Receptors Channels (1994) 2:155-163.
71. BLACKHALL WJ, PRICHARD RK, BEECH RN: Selection at a γ-aminobutyric acid receptor gene in Haemonchus contortus resistant to avermectins/milbemycins. Mol. Biochem. Parasitol. (2003) 131:137-145.
72. SKINNER TM, BASCAL ZA, HOLDEN-DYE L, LUNT GG, WOLSTENHOLME AJ: Immunocytochemical localization of a putative inhibitory amino acid receptor subunit in the parasitic nematodes Haemonchus contortus and Ascaris suum. Parasitol. (1998) 117:89-96.
73. SCHOFIELD CM, JENKINS A, HARRISON NL: A highly conserved aspartic acid residue in the signature disulfide loop of the α1 subunit is a determinant of gating in the glycine receptor. J. Biol. Chem. (2003) 278:34079-34083.
74. MIYAZAWA A, FUJIYOSHI Y, UNWIN N: Structure and gating mechanism of the acetylcholine receptor pore. Nature (2003) 423:949-955.
75. ENG JKL, BLACKHALL WJ, OSEI-ATWENEBOANA MY et al.: Ivermectin selection on β-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol. (2006) 150:229-235.
76. BOURGUINAT C, PION SDS, KAMGNO J et al.: Genetic polymorphism of the β-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms. Parasitology (2006) 132:255-262.
77. FREEMAN AS, NGHIEM C, LI J et al.: Amphidial structure of ivermectin-resistant and -susceptible laboratory and field strains of Haemonchus contortus. Vet. Parasitol (2003) 110:217-226.
78. PRICHARD RK, ROULET A: ABC transporters and β-tubulin in macrocyclic lactone resistance: prospects for marker development. Parasitology (2007) 134:1123-1132.
79. KWA MS, KOOYMAN FN, BOERSEMA JH, ROOS MH: Effect of selection for benzimidazole resistance in Haemonchus contortus on β-tubulin isotype 1 and isotype 2 genes. Biochem. Biophys. Res. Commun. (1993) 191:413-419.
80. PRICHARD RK: Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol. (2001) 17:445-453.
81. SCHWAB AE, BOAKYE D, KYELEM D, PRICHARD RK: Detection of benzimidazole-resistance associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection with albendazole and ivermectin treatment. Am. J. Trop. Med. Hyg. (2005) 73:234-238.
82. SCHWAB AE, CHURCHER TS, SCHWAB AJ, BASÁÑEZ MG, PRICHARD RK: Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti. Parasitology (2006) 133:589-601.
83. GILLEARD JS, BEECH RN: Population genetics of anthelmintic resistance in parasitic nematodes. Parasitology (2007) 134:1133-1147.
84. VON SAMSON-HIMMELSTJERNA G, BLACKHALL WJ, MCCARTHY JS, SKUCE PJ: Single nucleotide polymorphism (SNP) markers for benzimidazole resistance in veterinary nematodes. Parasitology (2007) 134:1077-1086.
85. PRICHARD RK: Markers for benzimidazole resistance in human parasitic nematodes? Parasitology (2007) 134:1087-1092.
86. MARTIN RJ, ROBERTSON AP: Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57. Parasitology (2007) 134:1093-1104.
87. NEVEU C, CHARVET C, FAUVIN A, CORTET J, CASTAGNONE-SERENO P, CABARET J: Identification of levamisole resistance markers in the parasitic nematode Haemonchus contortus using a cDNA-AFLP approach. Parasitology (2007) 134: 1105-1110.
88. MCCAVERA S, WALSH TK, WOLSTENHOLME AJ: Nematode ligand-gated chloride channels: an appraisal of their involvement in macrocyclic lactone resistance and prospects for developing molecular markers. Parasitology (2007) 134:1111-1121.